| abstract |
The present invention has the following general formula (I) having beneficial pharmacological properties, particularly an inhibitory effect on tyrosine kinase-mediated signaling. [Chemical 1] (I) In which R a , R b and R c are as defined in claim 1, their tautomers, their stereoisomers, mixtures thereof and their salts, especially inorganic Or their physiologically acceptable salts with organic acids or bases. The invention also relates to the use of said compounds in the treatment of diseases, in particular tumors and benign prostatic hypertrophy (BPH), pulmonary diseases and respiratory tract diseases, and their production. |